Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-09-006861
Filing Date
2009-03-13
Accepted
2009-03-13 11:05:02
Documents
1
Period of Report
2009-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2700
  Complete submission text file 0001140361-09-006861.txt   4632
Mailing Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FT. WASHINGTON PA 19034
Business Address 267-513-1870
Marshall Joseph W III (Reporting) CIK: 0001458584 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23047 | Film No.: 09678120